Results 211 to 220 of about 185,824 (352)
Humanoid Robotic Loading Enhances Mechanotransduction in Tendon Tissue Engineering. [PDF]
Liu Z +13 more
europepmc +1 more source
ABSTRACT Protein aggregation poses a significant risk to biopharmaceutical product quality, as even minor amounts of oligomeric species can compromise efficacy and safety. Rapid and reliable detection of protein aggregates thus remains a major challenge in biopharmaceutical manufacturing.
Jakob Heyer‐Müller +4 more
wiley +1 more source
Spatially-resolved optical monitoring of bioreactor cell growth. [PDF]
Gorecki J +6 more
europepmc +1 more source
Performance Of Membrane Bioreactor (Mbr) In High Phosphate Wastewater
M. I. Aida Isma +3 more
openalex +1 more source
ABSTRACT Biopharmaceutical manufacturing requires robust analytics and process controls throughout production to insure high yield of quality products. New methodologies for rapidly accessing and integrating data‐rich information from complex dynamic biological environments are of great interest.
Kayla Chun +8 more
wiley +1 more source
CFD Modelling Validated by PIV of Hydrodynamics in a Raceway Bioreactor: Dead Zone Detection and Flow Field Analysis. [PDF]
Zamora-Campos LA +6 more
europepmc +1 more source
Packed-bed Bioreactors as Versatile Tools for In Vitro Microbiome Studies.
Hunter D. Whittington
openalex +1 more source
Transfer Learning Approaches in Bioprocess Engineering: Opportunities and Challenges
ABSTRACT Transfer learning (TL) has recently emerged as a promising approach to overcoming one of the key limitations of bioprocess engineering: data scarcity. By leveraging knowledge from one bioprocess to another, TL allows existing models and data sets to be reused efficiently, accelerating process development, improving prediction accuracy, and ...
Daniel Barón Díaz +3 more
wiley +1 more source
Emerging Sustainable Bioprocess for the Valorization of Agave Bagasse for Single-Cell Protein Production. [PDF]
Leal-Urbina E +4 more
europepmc +1 more source
ABSTRACT Stem cell‐based therapies hold transformative potential for regenerative medicine, yet their progress is constrained by persistent variability in manufacturing and clinical performance. Conventional frameworks such as Quality by Design (QbD), though effective for drugs and biologics, struggle to accommodate the dynamic nature of living cell ...
Mee‐Hae Kim, Masahiro Kino‐oka
wiley +1 more source

